Stock EXEN EXALENZ BIOSCIENCE LTD
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Exalenz Bioscience Ltd

Equities

EXEN

IL0011048688

Delayed TEL AVIV STOCK EXCHANGE
Other stock markets
 		5-day change 1st Jan Change
- ILa -.--% Intraday chart for Exalenz Bioscience Ltd +1.39% +107.88%
2020 Meridian Bioscience, Inc. completed the acquisition of Exalenz Bioscience Ltd from Mori Arkin and others. CI
2020 Meridian Bioscience, Inc. agreed to acquire Exalenz Bioscience Ltd from Mori Arkin and others for approximately ILS 170 million. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exalenz Bioscience Ltd Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2017; Provides Earnings Guidance for the Year 2018 and Revenue Guidance for the Year 2019
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXEN Stock
  4. News Exalenz Bioscience Ltd
  5. Other languages